Last updated: 16 February 2024 at 11:16am EST

Paul Herzich Net Worth




The estimated Net Worth of Paul Herzich is at least $54.2 ezer dollars as of 2 December 2023. Paul Herzich owns over 7,238 units of Solid Biosciences Inc stock worth over $54,213 and over the last 2 years Paul sold SLDB stock worth over $0.

Paul Herzich SLDB stock SEC Form 4 insiders trading

Paul has made over 1 trades of the Solid Biosciences Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Paul exercised 7,238 units of SLDB stock worth $54,213 on 2 December 2023.

The largest trade Paul's ever made was exercising 7,238 units of Solid Biosciences Inc stock on 2 December 2023 worth over $54,213. On average, Paul trades about 2,413 units every 0 days since 2022. As of 2 December 2023 Paul still owns at least 7,238 units of Solid Biosciences Inc stock.

You can see the complete history of Paul Herzich stock trades at the bottom of the page.



What's Paul Herzich's mailing address?

Paul's mailing address filed with the SEC is C/O SOLID BIOSCIENCES INC., 500 RUTHERFORD AVENUE, THIRD FLOOR, CHARLESTOWN, MA, 02129.

Insiders trading at Solid Biosciences Inc

Over the last 7 years, insiders at Solid Biosciences Inc have traded over $9,620,465 worth of Solid Biosciences Inc stock and bought 13,973,934 units worth $97,227,521 . The most active insiders traders include Advisors Llcperceptive Life..., Capital Management, L.P.Ra ... és Rajeev M. Shah. On average, Solid Biosciences Inc executives and independent directors trade stock every 38 days with the average trade being worth of $1,822,871. The most recent stock trade was executed by Ian F Smith on 3 July 2024, trading 3,255 units of SLDB stock currently worth $24,380.



What does Solid Biosciences Inc do?

solid biosciences (solid) is a cambridge, ma based biotech company singularly focused on developing treatments and cures for duchenne muscular dystrophy (dmd). solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. condition-focused, our mandate is comprehensive; improving daily life for patients and attacking the roots of dmd.



What does Solid Biosciences Inc's logo look like?

Solid Biosciences Inc logo

Complete history of Paul Herzich stock trades at Solid Biosciences Inc

Dátum
#
Cég
Az érdekelt
Trans.
Tranzakció
Részvények száma Ár per részvény Teljes ár Részvények szíma után Forrás
2 Dec 2023 Paul Herzich
Műszaki vezérigazgató
Opció Gyakorlat 7,238 $3.01 $21,786
2 Dec 2023
7,238


Solid Biosciences Inc executives and stock owners

Solid Biosciences Inc executives and other stock owners filed with the SEC include: